Shibu P. Thomas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shibu P. Thomas has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
Harpal Singh Nandhra
2 shared publicationsAnand Jayaraman
1 shared publication
Latest Publications
- 8 April 2010
- Published by Taylor & Francis in Journal of Mental Health
- Vol. 19 (2) , 168-175
Systematic review of lamotrigine augmentation of treatment resistant unipolar depression (TRD)
Our aim was to review all the evidence of lamotrigine's effectiveness in treatment resistant depression after at least one failed antidepressant trial. We used a systematic search strategy to identify studies that included adults aged 18-65 years with a diagnosis of unipolar depression who had not responded to at least a 4-week course of a recommended dose of an antidepressant. We found only one randomized, double blind study that has been published, showing its effectiveness for treatment-resistant depression. In this study, lamotrigine was found statistically superior to placebo on the CGI scale for severity and improvement; however, it was not on the HAM-D (primary end point) and MADRS scales. There were a number of smaller non RCT's which are included. There is little evidence to guide the use of lamotrigine for depression that has not responded to a course of antidepressants. Treatment-refractory depression continues to be significant mental health problem and large RCT trials are needed to inform clinical practice.
- 8 April 2010
- Published by Taylor & Francis in Journal of Mental Health
- Vol. 19 (2) , 168-175
Systematic review of lamotrigine augmentation of treatment resistant unipolar depression (TRD)
Our aim was to review all the evidence of lamotrigine's effectiveness in treatment resistant depression after at least one failed antidepressant trial. We used a systematic search strategy to identify studies that included adults aged 18-65 years with a diagnosis of unipolar depression who had not responded to at least a 4-week course of a recommended dose of an antidepressant. We found only one randomized, double blind study that has been published, showing its effectiveness for treatment-resistant depression. In this study, lamotrigine was found statistically superior to placebo on the CGI scale for severity and improvement; however, it was not on the HAM-D (primary end point) and MADRS scales. There were a number of smaller non RCT's which are included. There is little evidence to guide the use of lamotrigine for depression that has not responded to a course of antidepressants. Treatment-refractory depression continues to be significant mental health problem and large RCT trials are needed to inform clinical practice.
- 15 October 2009
- Published by Physicians Postgraduate Press, Inc in The Primary Care Companion For CNS Disorders
- Vol. 11 (5) , 212-214
Early Intervention in Psychosis
To investigate the clinical and social factors determining the duration of untreated psychosis (DUP) in 2 groups of individuals with first-episode psychosis. Clinical and social variables were collected retrospectively from the case notes of 74 patients with first-episode psychosis (defined as 1 of the categories in the ICD-10 of psychotic episode arising from a functional or substance misuse cause). Patients were divided into 2 groups, one with a DUP less than 12 weeks (n = 46) and one with a DUP equal to or longer than 12 weeks (n = 28). The means, standard deviations, and medians were calculated for the total sample as well as for each group, and data from the 2 groups were compared to determine differences. The study was conducted from January 2006 to January 2008. Of the 74 patients, a longer DUP was significantly associated with being male (P = .025) and with having an insidious mode of onset (P < .001), comorbid substance misuse (P < .01), and less family support (P = .01). Conversely, shorter DUP was associated with acute presentation (P < .001). These findings suggest that a longer DUP is influenced by the early clinical course and by social variables. Early recognition of these predictors of prolonged DUP should have an impact on reducing DUP and potentially improving the prognosis.
- 15 October 2009
- Published by Physicians Postgraduate Press, Inc in The Primary Care Companion For CNS Disorders
- Vol. 11 (5) , 212-214
Early Intervention in Psychosis
To investigate the clinical and social factors determining the duration of untreated psychosis (DUP) in 2 groups of individuals with first-episode psychosis. Clinical and social variables were collected retrospectively from the case notes of 74 patients with first-episode psychosis (defined as 1 of the categories in the ICD-10 of psychotic episode arising from a functional or substance misuse cause). Patients were divided into 2 groups, one with a DUP less than 12 weeks (n = 46) and one with a DUP equal to or longer than 12 weeks (n = 28). The means, standard deviations, and medians were calculated for the total sample as well as for each group, and data from the 2 groups were compared to determine differences. The study was conducted from January 2006 to January 2008. Of the 74 patients, a longer DUP was significantly associated with being male (P = .025) and with having an insidious mode of onset (P < .001), comorbid substance misuse (P < .01), and less family support (P = .01). Conversely, shorter DUP was associated with acute presentation (P < .001). These findings suggest that a longer DUP is influenced by the early clinical course and by social variables. Early recognition of these predictors of prolonged DUP should have an impact on reducing DUP and potentially improving the prognosis.